ClinicalTrials.Veeva

Menu

Task Oriented Activities Based on NDT Therapy Principles

R

Riphah International University

Status

Completed

Conditions

Cerebral Palsy

Treatments

Other: Neurodevelopmental therapy treatment
Other: conventional physiotherapy

Study type

Interventional

Funder types

Other

Identifiers

NCT05903729
REC/RCR & AHS/23/0711

Details and patient eligibility

About

Cerebral palsy (CP) is one of the primary causes of disability effecting majority of pediatric population. Cerebral Palsy is considered a neurological disorder caused by a non-progressive brain injury or malformation that occurs while the child's brain is under development. The worldwide incidence of cerebral palsy is it affects three to four individuals out of 1000 individuals in the general population. Cerebral palsy has different types depending upon the severity of disease or the area of the body it is affecting. Amongst the different types of CP, spastic diplegia is the most common type which mainly affects the lower extremities and lesser extent to upper extremities. It mainly affects functional performance and gait.

Full description

This study will be conducted on 20 subjects which would be equally divided into experimental and control groups. Trunk control measurement scale (TCMS) and quality of upper extremity skills test (QUEST) will be the tools used in this study. Pre and post values of the effects of intervention will be evaluated. The significance of this study is that it will help us how to improve trunk control and upper extremity function in spastic dipegic children. Data will be analyzed using SPSS 22.0. Mean and standard deviation will be calculated. Appropriate statistical test will be used after checking normality of data.

Enrollment

20 patients

Sex

All

Ages

6 to 12 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • • Children with spastic diplegic cerebral palsy with age between 6 to 12 years.

    • Children with spastic diplegic cerebral palsy who are able to follow verbal commands.
    • Children with spastic diplegic cerebral palsy having level II or III of gross motor function classification system.

Exclusion criteria

  • • Children who are uncooperative and having neurological deficit.

    • Children with hearing deficit.
    • Children with epilepsy.
    • Children with cardiac anomalies which effect exercise tolerance.
    • Children having less than 6-month post-orthopedic surgery.
    • Children having less than 6-month post-botulinum toxin injection (BOTOX).

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

20 participants in 2 patient groups

neurodevelopmental therapy group
Experimental group
Description:
in this group patients wil be treated with task oriented activities using neurodevelopmental therapy principles. This group will receive therapy session for 1 hour 6 days a week and for 8 weeks. total sessions will be 48. this group will receive task oriented neurodevelopmental therapy for 30 mins and next 30 mins it will receive conventional treatment.
Treatment:
Other: Neurodevelopmental therapy treatment
conventional physiotherapy group
Experimental group
Description:
in this group patients will be treated with conventional physiotherpy treatment protocol. this group will receive therapy session for one hour, 6 times in a week for 8 weeks. total therapy sessions will be 48. this group will receive 30 mins conventional physiotherapy treatment and 30 mins task oriented neurodevelopmental therapy.
Treatment:
Other: conventional physiotherapy

Trial contacts and locations

1

Loading...

Central trial contact

Muhammad Asif Javed, MS; Imran Amjad, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems